NECFA
BSX icon

New England Capital Financial Advisors’s Boston Scientific BSX Stock Holding History

New England Capital Financial Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$566 Hold
13
– – ﹤0.01% 398
2026
Q1 		$832 Buy
13
+1
+8% +$80 ﹤0.01% 379
2025
Q4 		$1.14K Hold
12
– – ﹤0.01% 369
2025
Q3 		$1.17K Buy
12
+1
+9% +$104 ﹤0.01% 367
2025
Q2 		$1.18K Hold
11
– – ﹤0.01% 359
2025
Q1 		$1.11K Hold
11
– – ﹤0.01% 334
2024
Q4 		$983 Hold
11
– – ﹤0.01% 356
2024
Q3 		$922 Hold
11
– – ﹤0.01% 347
2024
Q2 		$848 Hold
11
– – ﹤0.01% 344
2024
Q1 		$754 Hold
11
– – ﹤0.01% 349
2023
Q4 		$636 Hold
11
– – ﹤0.01% 359
2023
Q3 		$581 Hold
11
– – ﹤0.01% 354
2023
Q2 		$595 Hold
11
– – ﹤0.01% 350
2023
Q1 		$551 Hold
11
– – ﹤0.01% 395
2022
Q4 		$502 Buy
+11
New +$476 ﹤0.01% 396

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

New England Capital Financial Advisors's BSX Position: Q2 2026 in Review

New England Capital Financial Advisors held its Boston Scientific (BSX) position steady in Q2 2026 at 13 shares worth $566. The position accounts for ﹤0.01% of the portfolio, ranked #398.

New England Capital Financial Advisors first reported a position in BSX in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.18K in Q2 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • New England Capital Financial Advisors held 13 shares of Boston Scientific worth $566 as of Q2 2026.
  • New England Capital Financial Advisors left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up ﹤0.01% of New England Capital Financial Advisors's portfolio in Q2 2026, its #398 holding.
  • New England Capital Financial Advisors first reported a position in Boston Scientific in Q4 2022 and has held it in 15 quarters since.
  • New England Capital Financial Advisors's Boston Scientific position peaked at $1.18K in Q2 2025.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on New England Capital Financial Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.